Posco agrees to develop new battery materials with Factorial. Posco Future M, the battery materials and chemicals unit of South Korea’s Posco Group, announced it has signed an agreement with Factorial ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

The biotech uses one of the world’s largest datasets and AI supercomputers to find new drugs, but continued losses and lack of commercial products keep risk levels high. Recursion Pharmaceuticals is a ...

Internally developed to break through R&D bottlenecks, Gammatron™ enables advanced cycle life prediction, optimized charging protocols, and smarter electrolyte discovery across battery chemistries ...

BOSTON--(BUSINESS WIRE)--Factorial Inc. (Factorial), an industry leader in solid-state battery technology, today announced the shipment of its first solid-state lithium-metal battery cells for drone ...

Sorry, you need to subscribe to read this article. If you would like to access this article you must become a Premium Subscriber. Premium subscribers receive complete ...